NIO
NIO Inc.
NIO offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
PHIN
PHINIA Inc.
PHIN has the edge over NIO overall, supported by stronger valuation and stronger modeled upside.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
PHIN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
PHIN's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
PHIN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 10x | $72.51 | — |
| Current | 15x | $72.51 | — |
| Cheap | 19x | $92.38 | +27% |
| Fair | 22x | $110 | +52% |
| Expensive | 25x | $121 | +67% |
Historical ranges are pointers, not guarantees.
PHIN's PE is in its cheap range at 15x. If earnings grow as analysts expect, today's price would be 10x next year's earnings.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
PHIN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for PHIN, with profitability improving.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
PHIN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.94 | +40% |
| Q3 2026 | $4.95 | +122% |
| Q2 2026 | $3.48 | +34% |
| Q1 2026 | $3.57 | +102% |
| Q4 2025 | $3.24 | +84% |
| Q3 2025 | $2.23 | -4.3% |
| Q2 2025 | $2.60 | +39% |
| Q1 2025 | $1.77 | -23% |
| Q4 2024 | $1.76 | -15% |
PHIN has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over PHIN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
PHIN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $912M | +0.4% |
| Q2 2026 | $940M | +5.6% |
| Q1 2026 | $878M | +10% |
| Q4 2025 | $889M | +6.7% |
| Q3 2025 | $908M | +8.2% |
| Q2 2025 | $890M | +2.5% |
| Q1 2025 | $796M | -7.8% |
| Q4 2024 | $833M | -5.6% |
PHIN's revenue has grown year over year for six quarters in a row: $912M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.2% | +5.5 points |
| Q2 2026 | 8.5% | -1.5 points |
| Q1 2026 | 7.9% | +0.1 points |
| Q4 2025 | 7.8% | +1.6 points |
| Q3 2025 | 3.7% | -4.1 points |
| Q2 2025 | 10% | +1.8 points |
| Q1 2025 | 7.8% | -0.4 points |
| Q4 2024 | 6.1% | -3.1 points |
PHIN has the edge over NIO on profitability, with a higher operating margin.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
PHIN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $70M | -25% |
| Q2 2026 | $69M | +200% |
| Q1 2026 | $21M | +320% |
| Q4 2025 | $67M | +26% |
| Q3 2025 | $93M | +33% |
| Q2 2025 | $23M | -75% |
| Q1 2025 | $5M | +$17M |
| Q4 2024 | $53M | +83% |
PHIN has the edge over NIO on cash flow, with more consistent year-over-year improvement.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PHIN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 1.6x | Healthy |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.2x | Healthy |
PHIN's net debt is about 1.4 years of its operating earnings (EBITDA), down from 1.6 years a year ago.
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
PHIN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.2 | Neutral |
| Stochastic | 55.5 | Neutral |
PHIN's weekly RSI is 56 (neutral) and its Stochastic is 55 (neutral).
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
PHIN PE vs Consumer Cyclical Sector
| Metric | PHIN | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 19% below |
| PE % | 1 | 35 | 34 pts below |
PHIN is trading at 15x earnings, a 19% discount to the Consumer Cyclical sector's median of 18x.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
PHIN has stronger trend alignment. NIO is above 0 of 5 weekly averages versus PHIN above 4 of 4.
PHIN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.4 | 16% above |
| 20 week MA | $68.6 | 5.6% above |
| 50 week MA | $70.2 | 3.3% above |
| 100 week MA | $59.6 | 22% above |
PHIN is in an uptrend: it's above all four of its weekly moving averages, and 22% above its 100-week average.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.
PHIN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $31.5 | $30.3 | -3.8% |
| 2024 | $30.3 | $48.2 | +59% |
| 2025 | $48.2 | $61.4 | +27% |
| 2026 YTD | $61.4 | $72.5 | +18% |
PHIN has the edge over NIO on returns for 2026, with the stronger performance.